Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

STDs

- PMLiVE

FDA approves J&J’s Bluetooth blood glucose monitor

Licenses iPhone, iPad and iPod Touch compatible monitoring system

Novartis to expand SMS for Life approach across Africa

Will broaden reach of mobile-based medicines management programme 

Apple curates HCP iPhone and iPad apps

Sanofi bags first pharma place on new iTunes App Store collection lists

- PMLiVE

Gilead settles patent dispute with Teva over Viread generic

Launch of generic HIV drug held back until December 2017

- PMLiVE

OncoAssist becomes latest app to be classified as a medical device

Cancer iPhone and iPad app offers clinical decision support tools

- PMLiVE

Sanofi backs SMS chemotherapy compliance programme

Prost8Care delivers timed text message encouragement to cancer patients

- PMLiVE

Anker Lundemose appointed CEO of Bionor Pharma

Will lead efforts to develop and commercialise HIV vaccines

- PMLiVE

How close are we to a tricorder?

The intersection of smartphones and medical technology is increasing the pace of change

- PMLiVE

Boehringer launches COPD patient consultation app for HCPs

Extends reach of the calculator tools on its COPD Exchange website

Melanoma smartphone app claims ‘highly variable’

Applications that assess skin cancer risk often misclassify lesions

- PMLiVE

FDA-approved iPhone heart monitor now available

AliveCor's device can initially only be bought by US healthcare professionals

- PMLiVE

Sexual health apps fail to attract smartphone users

HIV and STD apps not fulfilling their potential to assist with prevention and care

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links